Cargando…
Myocardial and Pericardial Toxicity Associated With Immune Checkpoint Inhibitors in Cancer Patients
We recount a single-center experience with cardiac immunity-related adverse effects in patients treated with immune checkpoint inhibitors. Of 2,830 patients, 9 patients (0.3%) developed cardiac immunity-related adverse effects (4 cases of cardiomyopathies, 2 of myocarditis, 2 of acute pericarditis,...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298653/ https://www.ncbi.nlm.nih.gov/pubmed/34317203 http://dx.doi.org/10.1016/j.jaccas.2019.11.080 |